well the market has discounted this stock for some time.
As a LTH seen everything said and argued on the OSL forum recent years.
cannot ignore case made @vrs37. You need the medical community to jump on board faster.
a sale and a new jurisdiction approval positive but we need a meaningful take up
been patient for 5 years but a true thoroughbred needs to stop eating chaff.
still have faith but it’s 2021 for me - opportunity cost of ignoring others becomes compelling.
Ann: OncoSil receives Swiss regulatory approval, page-13
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $50.21K | 4.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7425926 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 2122533 | 4 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |